MorphoSys, Shionogi Extend Research Partnership by Three Years

MorphoSys AG (MOR) and Shionogi & Co. Ltd. agreed to extend their research partnership by three years, giving the German biotechnology company undisclosed annual user fees. Further financial details weren’t revealed.

To contact the editor responsible for this story: Angela Cullen at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.